COMPARATIVE DOCKING ANALYSIS REVEALS DIVERGENT SGLT2 SELECTIVITY, FAVORING DAPAGLIFLOZIN

Background: Sodium-glucose cotransporter 2 (SGLT2) inhibitors are widely used in type 2 diabetes therapy, but selectivity over SGLT1 is critical to minimize gastrointestinal side effects. Objectives: To evaluate and compare the selectivity of SGLT inhibitors, especially Dapagliflozin and Empaglifloz...

Cijeli opis

Bibliografski detalji

Glavni autori:	I Dewa Agung Panji Dwipayana, Ni Luh Putu Kayika Febryanti, Made Pharmawati
Format:	Artigo
Jezik:	Inglês
Izdano:	Faculty of Medicine, Universitas Diponegoro 2026-07-01
Serija:	Jurnal Kedokteran Diponegoro
Teme:	dapagliflozin, empagliflozin, docking, adme, toxicity, sglt1, sglt2
Online pristup:	https://ejournal3.undip.ac.id/index.php/medico/article/view/53412
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!